Three of seven COVID-19 vaccine stocks have outperformed the S&P 500 since the beginning of the global pandemic. Novavax is the highest performing vaccine stock, returning 1,549% to shareholders
Source: https://www.visualcapitalist.com/vaccine-stocks-1000-invested-return/
